about
Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Recombinant adeno-associated viruses (rAAV2) facilitate the intraperitoneal gene delivery to cancer cellsFatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting signaling pathways in ovarian cancer.
@en
Targeting signaling pathways in ovarian cancer.
@nl
type
label
Targeting signaling pathways in ovarian cancer.
@en
Targeting signaling pathways in ovarian cancer.
@nl
prefLabel
Targeting signaling pathways in ovarian cancer.
@en
Targeting signaling pathways in ovarian cancer.
@nl
P2860
P1476
Targeting signaling pathways in ovarian cancer
@en
P2093
J Reibenwein
P2860
P304
P356
10.1517/14728222.12.3.353
P407
P577
2008-03-01T00:00:00Z